Some Sanofi plant workers having to self-quarantine, CEO says by Eric Sagonowsky Friday, April 3, 2020 Sanofi, a hydroxychloroquine maker, is producing as much as it can amid the pandemic, but some workers are having to exit the line manufacturing line.
What to expect from the COVID-19 vaccine race? Experts weigh in by Eric Sagonowsky Tuesday, March 31, 2020 Amid the COVID-19 pandemic, many teams of researchers are working on potential vaccines. We asked experts to assess progress—and point out challenges.
Sanofi, Regeneron launch Kevzara coronavirus study outside U.S. by Kyle Blankenship Monday, March 30, 2020 Weeks after launching a U.S. trial to evaluate IL-6 inhibitor Kevzara for COVID-19, Sanofi and Regeneron have launched a matching study abroad.
ACC: Amgen's Repatha cuts cholesterol in HIV patients by Kyle Blankenship Saturday, March 28, 2020 Amid Amgen's pricing war with Sanofi and Regeneron's Praluent, PCSK9 cholesterol fighter Repatha has shown a clinical benefit for HIV patients.
Drugmakers look to repurposed meds for COVID-19 therapeutics by Kyle Blankenship, Fraiser Kansteiner Wednesday, March 25, 2020 With drugmakers on the hunt for COVID-19 therapeutic, could one of a range of repurposed meds offer a solution? We run down the latest options.
Inside Regeneron, shared urgency drives COVID-19 efforts by Kyle Blankenship Friday, March 20, 2020 Through weeks of sleepless nights and conference calls, Regeneron's research team is well positioned to solve COVID-19 with regulators' backing.
EUSA Pharma opens COVID-19 trial for IL-6 inhibitor Sylvant by Kyle Blankenship Wednesday, March 18, 2020 With Sanofi and Regeneron testing IL-6 med Kevzara to treat COVID-19, another drug in the class is rolling into testing in an Italian hospital.
Sanofi touts supply chain integrity, predicts no shortages by Fraiser Kansteiner Tuesday, March 17, 2020 While Sanofi zeroes in on coronavirus vaccine work and tests Kevzara against COVID-19, the company's working to safeguard supplies, too.
Pharma sales reps stay home, use digital tools to contact docs by Beth Snyder Bulik Tuesday, March 17, 2020 As COVID-19 spreads, pharma's forcing sales reps to stay at home, subbing digital tools and virtual meetings for face-to-face physician visits.
Sanofi, Regeneron roll Kevzara into COVID-19 trials immediately by Kyle Blankenship Monday, March 16, 2020 Sanofi and Regeron aim to fast track arthritis med Kevzara for use in novel coronavirus patients with an immediate phase 2/3 global clinical program.
